Clinical Trial: A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies

U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07476378) titled 'A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies' on March 12.

Brief Summary: This is an investigator-initiated, open-label, single-arm, dose-escalation and dose-expansion study to evaluate the safety, tolerability, PK, PD, and preliminary efficacy of MTM-H-001 in adult participants with relapsed/refractory (R/R) B-cell malignancies.

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Lymphoma, Large B-Cell, Diffuse (DLBCL) Lymphoma, Follicular Lymphoma, Mantle-Cell Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Lymphoma, B-Cell, M...